| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.1M | -51.9% |
| SG&A Expense | $17.0M | +181.9% |
| Operating Income | -$20.1M | -61.7% |
| Pre-tax Income | -$42.1M | -245.2% |
| Income Tax | -$6.2M | — |
| Net Income | -$35.9M | -194.5% |
| EPS (Basic) | -$1.12 | +88.1% |
| EPS (Diluted) | -$1.12 | +88.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $17.4M | +367.2% |
| Total Assets | $519.1M | — |
| Current Liabilities | $3.3M | +36.1% |
| Total Liabilities | $121.2M | +4921.6% |
| Stockholders' Equity | $397.9M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.1M | -47.9% |
| Investing Cash Flow | -$77.6M | — |
| Financing Cash Flow | $107.2M | +2939.5% |